SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
GXDX Analysis & Videos »
GXDX: Bull or Bear?
Have Your Say on Healthcare Reform
GXDX
|
|
|
+16.49%
in
349 days
<> Visit the Change.gov website to submit your ideas on healthcare reform as the new Obama-Biden administration prepares for their inauguration on January 20, 2009. Tom Daschle will serve as Secretary of Health & Human Services and is encouraging the nation to share their healthcare experiences and suggestions to improve and reform healthcare in the U.S.
A key feature of the plan is making health insurance coverage possible for all Americans using the existing network of insurers and providers. The plan relies on tax credits for sm...
|
A New Index of Preventive Medicine Cos.
GXDX
|
|
|
+17.92%
in
3 days
(closed on 12/07/08)
<> 
The accompanying table [click to enlarge] presents statistics and the top 15 rated companies in the ETF Innovators [ETFI] Preventive Medicine Index. The index includes U.S.-listed companies with market caps of $200M-$60B which are engaged in the following healthcare business segments: vaccine makers, diagnostics, lab services, and diabetes care.
The index has outpaced the overall market, Healthcare Sector SPDR (XLV), HealthShares Diagnostics (HHD), and iShares Nasdaq Biotech (IBB) over the past year, posting ...
|
Obama-Care Focused on Preventive Medicine
GXDX
|
|
|
-18.93%
in
29 days
(closed on 12/04/08)
<> 
In addition to bullish outlooks for generic drugs and Health IT , President-Elect Obama's healthcare plan plans to focus on public health initiatives and mandated coverage of preventive services such as cancer screenings. The accompanying table presents statistics and the top five rated companies in the ETFI Preventive Medicine Index, including vaccine makers such as Emergent BioSolutions (EBS), diabetes care companies such as Novo Nordisk (NVO), diagnostic companies such as Sequenom (SQNM) and Myriad Geneti...
|
Bookkeeping: Starting Genoptix (GXDX) Position
GXDX
|
|
|
+3.55%
in
444 days
Genoptix (GXDX) is a company I found this weekend in my search for "things that are working" and this $550M market cap company that came public last October, has a very straightforward business.
<>Genoptix is a specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to community-based hematologists and oncologists. Our highly trained group of hemepaths utilize sophisticated diagnostic technologies to provide a differentiated, specialized, and integrated assessment of a patients condition, aiding physicians in making vital decisions conce...
|
GXDX - good pick - IPO
GXDX
|
|
|
+7.36%
in
456 days
GXDX is a company that does laboratory service and works with blood and cancer. They are ran by many Ph. D's and MD's so the company actually has a product that works. Their earning are increasing and they have beaten earnings estimates for the past year!
Very very good pick in my opinion.
They also had an IPO in the last year.
|
Genoptix (GXDX) "Trading Transparency"
GXDX
|
|
|
+4.79%
in
456 days
Hello Friends! Thanks so much for stopping by and visiting my blog, Stock Picks Bob's Advice! As always, please remember that I am an amateur investor, so please remember to consult with your professional investment advisers prior to making any investment decisions based on information on this website. 
<>First of all I would like to apologize for the paucity of posts on the blog the last week or two. I would encourage you all to utilize my Covestor Page to find out how my actual holdings are doing when I am not blogging. And I shall try to get back 'in the saddle' once again, and<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>< /><><><><><><><><><><><><><><><>...
|
Adding 5% To GXDX
GXDX
|
|
|
+6.77%
in
28 days
(closed on 09/02/08)
10% of index now allocated to GXDX.
Update: Filled at $34.18 @ 10:06 am.
|
Adding GXDX To Index
GXDX
|
|
|
+4.07%
in
15 minutes
(closed on 08/04/08)
5% of index allocated to GXDX.
Updated: Filled at $35.25 @ 10:28 am.
|
Chart Attack
GXDX
+15.15%
in
556 days
Here are selected charts from my watchlist.
SRX: Breakdown-pullback with bearish flag forming.
FSLR: Momuntume breakout. Hot sector. Overbought so I'd wait for a pullback.
LEH: Weak downtrend consolidation. If it falls, lots of room to drop. Easy stop placement limits risk.
ICO: Nice Uptrend. Possible buy on low volume dip to 20 day moving average.
GXDX: Nice breakout after
|
Genoptix, Inc. (GXDX) - Focus, Loyalty, and Growth
GXDX
|
|
|
+16.60%
in
557 days
Genoptix, Inc. (GXDX) is a relatively small player in the laboratory diagnostic field, and yet it is one of the most well respected companies within its field. The firm focuses exclusively on serving Hematologists and Oncologists in diagnosing their patient’s illnesses. Most of the diagnostic tests are run on bone marrow samples which [...]
|
Genoptix: Little-Known Biotech with Strong Focus and Growth
GXDX
+15.15%
in
556 days
<>Genoptix, Inc. (GXDX) is a relatively small player in the laboratorydiagnostic field, and yet it is one of the most well respectedcompanies within its field. The firm focuses exclusively on serving hematologists and oncologists in diagnosing their patients’ illnesses.Most of the diagnostic tests are run on bone marrow samples which arevery difficult and painful to extract from the patients. Becausedoctors consider these samples so precious, and the prospect ofpotentially drawing another sample is so unattractive, doctorstypically are receptive to sending samples to this smaller morespeciali< /><>...
|
Genoptix Inc (GXDX) - Selling Shareholders Create Opportunity
GXDX
|
|
|
+17.00%
in
69 days
(closed on 05/13/08)
In the healthcare arena there are many large companies that dominate particular sectors of the industry. But from time to time, new players emerge with attractive unique focuses which help to revitalize the overall arena. Genoptix (GXDX) is an up and coming diagnostic firm which caters exclusively to hematologists and oncologists. The tests that Genoptix [...]
|
Genoptix Inc (GXDX) - Selling Shareholders Create Opportunity
GXDX
|
|
|
+0.00%
in
0 minute
(closed on 03/05/08)
In the healthcare arena there are many large companies that dominate particular sectors of the industry. But from time to time, new players emerge with attractive unique focuses which help to revitalize the overall arena. Genoptix (GXDX) is an up and coming diagnostic firm which caters exclusively to hematologists and oncologists. The tests that Genoptix [...]
|
Beginning to prove its worth
GXDX
|
|
|
+13.10%
in
418 days
(closed on 06/03/09)
GXDX moved 13% on Friday, this companies incredible earnings and sales growth make this stock have the ability to make a run at higher ground. Stocks who show tremendous sales and earnings growth tend to outperform the broader market on a 6-18 month time frame. GXDX has broken out on strong volume, coupled with its growth qualities makes this stock an ideal long.
Remember to cut your losses quickly, 8-10% is where I cut my losses. Since GXDX is greater than 10% away from its 50dma an entry here is slightly more risky. However, given a great cut loss strategy you can avoid la...
|
People Bullish on GXDX
People Bearish on GXDX
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on GXDX |
Be the first to start a discussion and earn 2 points.
More Resources
|
About Genoptix Inc.
- Answers.com
